Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Boutron

Showing results (141-150 of 291) with videos related to

Pageof 30
Sort By:
Scientific Reports|August 2, 2017
Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker TestingAlexandre Vivot, Isabelle Boutron, Geoffroy Béraud-Chaulet, et al.
BMJ Open|November 20, 2017
Interpretation of health news items reported with or without spin: protocol for a prospective meta-analysis of 16 randomised controlled trialsRomana Haneef, Amélie Yavchitz, Philippe Ravaud, et al.
Plos Medicine|September 18, 2012
Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort studyAmélie Yavchitz, Isabelle Boutron, Aida Bafeta, et al.
BMJ Evidence-Based Medicine|January 9, 2025
Peer reviewers' conflicts of interest in biomedical research: scoping reviewChristoffer Bruun Korfitsen, Camilla Hansen Nejstgaard, Asbjørn Hróbjartsson, et al.
BMJ Open|March 24, 2016
Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysisCéline Buffel du Vaure, Philippe Ravaud, Gabriel Baron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trialIsabelle Boutron, Douglas G Altman, Sally Hopewell, et al.
Journal of Clinical Epidemiology|March 10, 2020
Future of evidence ecosystem series: 3. From an evidence synthesis ecosystem to an evidence ecosystemPhilippe Ravaud, Perrine Créquit, Hywel C Williams, et al.
Plos One|February 2, 2016
Assessment of a Standardized Pre-Operative Telephone Checklist Designed to Avoid Late Cancellation of Ambulatory Surgery: The AMBUPROG Multicenter Randomized Controlled TrialSonia Gaucher, Isabelle Boutron, Florence Marchand-Maillet, et al.
Journal of Clinical Epidemiology|April 30, 2026
A scoping review of ICHOM Sets identifies a small number of commonly recommended baseline characteristicsMelanie Salman, Viet-Thi Tran, Isabelle Boutron, et al.
Annals of Surgery|March 28, 2014
Reply to Letter: "Equivalence Approach Is More Appropriate for Comparison of Treatment Effect Estimates"Guillaume Lonjon, Isabelle Boutron, Ludovic Trinquart, et al.
Pageof 30

Showing results (141-150 of 291) with videos related to

Sort By:
Pageof 30
Scientific Reports|August 2, 2017
Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker TestingAlexandre Vivot, Isabelle Boutron, Geoffroy Béraud-Chaulet, et al.
BMJ Open|November 20, 2017
Interpretation of health news items reported with or without spin: protocol for a prospective meta-analysis of 16 randomised controlled trialsRomana Haneef, Amélie Yavchitz, Philippe Ravaud, et al.
Plos Medicine|September 18, 2012
Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort studyAmélie Yavchitz, Isabelle Boutron, Aida Bafeta, et al.
BMJ Evidence-Based Medicine|January 9, 2025
Peer reviewers' conflicts of interest in biomedical research: scoping reviewChristoffer Bruun Korfitsen, Camilla Hansen Nejstgaard, Asbjørn Hróbjartsson, et al.
BMJ Open|March 24, 2016
Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysisCéline Buffel du Vaure, Philippe Ravaud, Gabriel Baron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trialIsabelle Boutron, Douglas G Altman, Sally Hopewell, et al.
Journal of Clinical Epidemiology|March 10, 2020
Future of evidence ecosystem series: 3. From an evidence synthesis ecosystem to an evidence ecosystemPhilippe Ravaud, Perrine Créquit, Hywel C Williams, et al.
Plos One|February 2, 2016
Assessment of a Standardized Pre-Operative Telephone Checklist Designed to Avoid Late Cancellation of Ambulatory Surgery: The AMBUPROG Multicenter Randomized Controlled TrialSonia Gaucher, Isabelle Boutron, Florence Marchand-Maillet, et al.
Journal of Clinical Epidemiology|April 30, 2026
A scoping review of ICHOM Sets identifies a small number of commonly recommended baseline characteristicsMelanie Salman, Viet-Thi Tran, Isabelle Boutron, et al.
Annals of Surgery|March 28, 2014
Reply to Letter: "Equivalence Approach Is More Appropriate for Comparison of Treatment Effect Estimates"Guillaume Lonjon, Isabelle Boutron, Ludovic Trinquart, et al.
Pageof 30